Tag Archives: variant

New malware variant has “radio silence” mode to evade detection – BleepingComputer

  1. New malware variant has “radio silence” mode to evade detection BleepingComputer
  2. Pandas with a Soul: Chinese Espionage Attacks Against Southeast Asian Government Entities Check Point Research
  3. Sharp Panda Using New Soul Framework Version to Target Southeast Asian Governments The Hacker News
  4. Sharp Panda Target Southeast Asia in Espionage Campaign Expansion Infosecurity Magazine
  5. “Sharp Panda”: Check Point Research puts a spotlight on Chinese origined espionage attacks against southeast asian government entities Check Point Blog
  6. View Full Coverage on Google News

Read original article here

The world needs to ‘calm down’ about the risk of a new COVID variant emerging from China, the country’s former CDC chief says – Fortune

  1. The world needs to ‘calm down’ about the risk of a new COVID variant emerging from China, the country’s former CDC chief says Fortune
  2. China Lancet Study Says No New Variants Emerged During Latest COVID-19 Outbreak | English News CNN-News18
  3. World should ‘calm down’ about China Covid variants: Chinese scientist The Indian Express
  4. New Covid variants in China? Top scientist’s ‘keep calm and carry on’ message Hindustan Times
  5. China’s Covid Deaths and Severe Cases Both Slide 98% From Peak Levels Bloomberg
  6. View Full Coverage on Google News

Read original article here

The ‘Kraken’ COVID variant taking hold in the U.S. Here’s how many vaccine shots there are—and what experts recommend to protect yourself

Another highly contagious COVID-19 variant called XBB.1.5 has made its way to the U.S. with the World Health Organization (WHO) calling it “the most transmissible” variant to date.

Coined “Kraken” by a Canadian biology professor, the new variant is laying down roots in the U.S, although the U.S. Centers for Disease Control and Prevention (CDC) have had some wavering data on how many cases “Kraken” has caused. It now estimates that the variant will make up over a fourth of total cases this week.

“That doesn’t mean the variant will cause more or less severe disease than previous versions of COVID,” says Dr. Charles Miramonti, a senior medical director at Oak Street Health in Indianapolis, Indiana. “But it does spread more effectively than previous strains.”

As talk of a winter surge looms, you may be wondering about your level of immunity and if you can evade infection by yet another strain. Now that it’s been over two years since the authorization of the first COVID-19 vaccines, followed by booster rollouts, you may be confused about how many COVID shots there are out there, and whether you are protected.

How many COVID shots have there been?

Health officials have recommended four shots to most people, Miramonti says.

Four types of COVID-19 vaccines have been made available in the U.S: Pfizer-BioNTech, Moderna, Novavax, and Johnson & Johnson. Johnson & Johnson’s is a single-dose vaccine, but all others are a two-dose regimen. These doses are part of the primary, or initial, series of vaccines against the virus.

Due to immunity waning over time, booster shots became available to keep people continuously protected. Pfizer and Moderna offered a booster to their m-RNA vaccines in the fall of 2021. In the fall of 2022, they also offered a bivalent booster, which specifically targets the Omicron sub-variants that have dominated the country.

Johnson & Johnson’s original dose has since been limited to people who clinically cannot get the Pfizer or Moderna vaccine or for those who would otherwise forgo vaccination. If you had their single-dose vaccine, you were eligible for both boosters from Pfizer or Moderna.

Novavax, which was authorized for use in the U.S. much later than the others and isn’t as commonly used, has a booster. While it’s not an updated bivalent booster, it’s thought to potentially offer broader protection. Its manufacturer says its original formula offers protection against several COVID strains, including Omicron BA.5, according to Yale Medicine.

If you’re older and/or moderately or severely immunocompromised, you may have received up to two additional “booster” doses of the original vaccine, in addition to a dose of the updated Omicron vaccine this fall. People over 50 have also been eligible for an additional booster as of spring 2022.

These are the three most common COVID vaccines and the number of shots associated with them

The two-dose Moderna Vaccine

  • 4 shots: two shots for the primary dose, one booster which became available in the fall of 2021, and the new bivalent booster available as of September 2022

  • Some people may have 5 shots if they are over 50 or immunocompromised

The two-dose Pfizer Vaccine

  • 4 shots: two shots for the primary dose, one booster which became in the fall of 2021, and the new bivalent booster available as of September 2022

  • Some people may have 5 shots if they are over 50 or immunocompromised

The one-dose Johnson & Johnson vaccine

  • 3 shots: one shot for the primary dose, and two boosters from Moderna or Pfizer when they became authorized in the Fall of 2021, and then in 2022 respectively. The CDC says mixing and matching works fine for people in this category.

  • Some people may have 4 shots if they are over 50 or immunocompromised

There are some nuances to how many vaccines and boosters are generally available. Some people with weakened immune systems qualify for an additional dose, which works to “improve immunocompromised people’s response to their initial vaccine series,” according to Johns Hopkins Medicine.

Do the boosters help against new variants?

Experts explain that while new variants can be immune-evasive, getting vaccinated and boosted is the best way to stay protected from infection and getting severely ill. It’s still early to say with certainty how well the vaccine will work against “Kraken,” derived from Omicron, but experts believe it will likely be generally as effective as other variants.

It is not too late to get the bivalent booster, which will be the most effective booster against the current strains from getting severely sick, says Dr. Preeti Malani, an infectious disease specialist at the University of Michigan.

“The name of the game is to not get hospitalized if you’re vulnerable,” she says.

For those who want a bivalent booster, you must be at least two months past your primary series. If you have recently had COVID and want to get the bivalent booster, consider delaying your appointment by three months from the onset of symptoms or a positive test.

The more a variant circulates in a community, the more it can mutate and evade immunity from both vaccination and prior infection. Since getting vaccinated can help reduce the spread of the virus, getting as many people as possible vaccinated in a community minimizes the chance of new variants developing.

“Updated COVID-19 boosters can help restore protection that has decreased since previous vaccination,” the CDC says.

Do you need another COVID booster?

There is not a new booster that is targeting “Kraken” as of now. Experts instead point to the low rates of vaccination and booster vaccination for the already available ones.

The vast majority of children have not been vaccinated at all, per data from November from the CDC. In a survey from Morning Consult conducted in November, nearly half of U.S. adults who are vaccinated and did not receive a booster from September to November said they do not plan to get the bivalent one, many people citing that they don’t have time to get one or don’t see the point.

As the variants change, vaccine fatigue and, now, booster fatigue, has set in, but remaining up-to-date on vaccines and boosters that are authorized can help you do your part in limiting the spread.

“The newest boosters are still saving lives and keeping people out of the hospital,” Miramonti says. “They’re keeping secondary infections to a minimum,” adding they protect people against longer-term complications from COVID that can weaken the immune system.

This story was originally featured on Fortune.com

More from Fortune:
Air India slammed for ‘systemic failure’ after unruly male passenger flying business class urinated on a woman traveling from New York
Meghan Markle’s real sin that the British public can’t forgive–and Americans can’t understand
‘It just doesn’t work.’ The world’s best restaurant is shutting down as its owner calls the modern fine dining model ‘unsustainable’
Bob Iger just put his foot down and told Disney employees to come back into the office

Read original article here

New COVID Variant Sends NYC Case Rates Soaring; Hospitalizations High – NBC New York

What to Know

  • You’ve probably heard about the XBB.1.5 variant; it’s the latest “most transmissible COVID variant yet” and appears to be better at binding to human cells, which may make it more adept at infecting
  • There’s no evidence at this point that the strain, a combination of two prior omicron subvariants, is more lethal or more likely to cause COVID complications, but as a top White House official said last week, if you haven’t been vaccinated or infected lately, your protection probably isn’t so good
  • Nowhere is XBB.1.5 more prevalent than in the northeastern United States, according to the CDC — and rolling hospitalization and death rates, along with cases, are climbing accordingly

COVID-19 hospitalizations in New York and New Jersey have soared to 11-month highs as the most transmissible variant yet, a combination of two prior omicron strains, fuels yet another infection wave nearly three full years into the pandemic, the latest federal health data show.

Deaths are also climbing, with weekly fatality reports for both states currently at their highest levels since early last year, according to the CDC. In New York City, the rolling COVID fatality average is the highest it’s been since February 2022, while rolling hospitalizations are at a height not seen since the downswing of the initial omicron wave.

CDC COVID guidelines say face masks should be worn across the board in New York City, Long Island and much of the Hudson Valley, given the high spread rate. And the entire state of New Jersey is at the agency’s highest risk level, its latest data shows. While elected officials and their health departments have advised people to follow those guidelines, especially if they’re more vulnerable in terms of age or underlying conditions, no new mandates have been issued.


CDC

COVID community levels in NY



CDC

COVID community levels in NJ


And no new mandates are expected, either, at this point in the pandemic.

New York Gov. Kathy Hochul and New Jersey Gov. Phil Murphy, both of them Democrats, are each set to deliver their State of the State addresses on Tuesday. It remains to be seen whether the ongoing COVID response will once again play a feature role in those speeches. Given these charts, the odds are fairly likely.

NEW YORK STATE COVID TRENDS (via CDC)

HOSPITALIZATIONS



CDC


CASES AND DEATHS


CDC

COVID cases and deaths in New York via CDC


Last week, New York state’s Department of Health announced the XBB.1.5 variant is far and away the most dominant strain locally, accounting for more than 50% of statewide infections. That share is likely considerably higher, given the relatively low proportion of positive tests that undergo the exhaustive genetic sequencing process to isolate variants.

The same can be said for New Jersey, where the 38.4% share of sequences cases tied to XBB.1.5 reflects data not updated since mid-December. In New York City, where data also lags, XBB.1.5’s prevalence is likely well above the 68% share that the health department last updated on Christmas Eve.

NEW JERSEY COVID TRENDS


CDC

New Jersey COVID hospitalization trends



CDC

New Jersey COVID case and death trends


The latest CDC data suggests that XBB.1.5 is spreading in the northeastern United States at a much higher rate than the rest of the country, accounting for up to 81% of cases in the region comprising New York and New Jersey compared with a 43% high estimate for the nation.

While there is “not yet clear evidence,” according to New York state, that XBB.1.5 significantly affects COVID’s virulence or disease severity, early data does indicate it is more infectious than other circulating variants. The fact it has emerged at a time when both COVID and flu cases remain high is further cause for heightened caution, it says.

New York City positivity rates are bearing out the transmissibility concerns, with more than a third of neighborhoods across the five boroughs seeing those numbers in excess of 20% — and some spots topping 30% positivity.

NYC COVID VARIANT AND HOSPITALIZATION DATA


NYC

This chart represents COVID variants in NYC. The top line is XBB.1.5.



NYC Health Department

NYC COVID hospitalization trends


Omicron is still classified as a variant of concern according to the CDC and the World Health Organization. That strain, which first emerged in South Africa in November 2021, though likely was there earlier, is the only variant of concern currently in circulation, according to WHO.

To be a variant of concern, WHO says a strain must be associated with one or more of the following changes at a degree of global significance:

  • Increase in transmissibility or detrimental change in COVID-19 epidemiology; OR
  • Increase in virulence or change in clinical disease presentation; OR
  • Decrease in effectiveness of public health and social measures or available diagnostics, vaccines, therapeutics

The CDC said the new COVID-19 variant is responsible for 75% of new cases.

Given their level of infectiousness and ongoing mutation, WHO advises each omicron descendant be monitored distinctly. That’s what officials in New York and New Jersey continue to do as they plead with the public to double down on the mitigation factors that have proven to work since the onset of the pandemic, from hand-washing and staying home when sick to vaccination, masking up in crowded areas and getting tested regularly.

Hochul continues to urge New Yorkers — and so does the White House — to get their updated bivalent booster shots if they haven’t already (see vaccine data). The head of the White House Task Force on COVID recently underscored the point, saying if you haven’t been infected lately or had that booster, you’re likely not protected from XBB.1.5.

Overall, experts say that healthy, vaccinated people still are at much lower risk for COVID complications than immunocompromised or un- and undervaccinated people.

As Hochul said in her latest COVID update, “I urge everyone to remain vigilant and continue to use all available tools to keep themselves, their loved ones and their communities safe and healthy. Stay up to date on vaccine doses, and test before gatherings or travel. If you test positive, talk to your doctor about potential treatment options.”


Read original article here

Custom XFX Radeon RX 7900 XTX card has been listed for $1099 by Amazon, XT variant for $979

Custom XFX 7900 XTX get first pricing leak

The XFX RX 7900 Merc 310 series are now listed on Amazon.

The launch of Radeon RX 7900 series is just a few days away. Meanwhile, online retailers such as Amazon are now seemingly ready for the upcoming launch. What is important, it is not just reference cards that are listed by the retailer anymore.

XFX upcoming Speedster MERC 310 GPU had briefly appeared on Amazon with a price and release date. This information is no longer listed by the retailer, but it was captured and shared by hardware leaker @momomo_us. The current page no longer shows this information.

XFX Radeon RX 7900 XT, Source: Amazon

According to this, RX 7900XTX would cost $1099, which is $100 above AMD MSRP. At the same time, custom RX 7900 XT from the same series gets $80 higher price than AMD is suggesting for its reference models. This card would cost $979.

As shown above, both cards would be still significantly cheaper than custom RTX 4080 models currently sold by Amazon and many other retailers. That’s a difference of at least 380 dollars.

We managed to find both listing on Amazon, but none of them has the price or release date as shown above. However, it does appear that price for XFX cards has now been confirmed. Both cards are now set to launch on December 13th, so just when AMD officially lifts its sales embargo.

AMD Radeon RX 7900 Specifications
VideoCardz.com Radeon RX 7900 XTX Radeon RX 7900 XT Radeon RX 6950XT GeForce RTX 4090 GeForce RTX 4080
Picture
Architecture RDNA3 (TSMC N5) RDNA3 (TSMC N5) RDNA2 (TSMC N7) Ada (TSMC 4N) Ada (TSMC 4N)
GPU Navi 31 XTX Navi 31 XT Navi 21 KXTX AD102-300 AD103-300
GPU Clusters
FP32 Cores
Base Clock
Game Clock
Boost Clock
Memory
Memory Bus
Memory Speed
Large Cache
Bandwidth
Board Power
Power Connectors 2 × 8-pin 2 × 8-pin 2 × 8-pin 1 × 16-pin 1 × 16-pin
PCIe Interface Gen4 x16 Gen4 x16 Gen4 x16 Gen4 x16 Gen4 x16
MSRP
Launch Date December 13th, 2022 December 13th, 2022 May 10th, 2022 October 12th, 2022 November 16th, 2022

Source: Amazon (7900XTX), Amazon (7900XT) (affiliate links)





Read original article here

Eminem and Spider-Man have a rap battle on Amazing Spider-Man #1 variant cover

Hip-hop superstar and recent Rock & Roll Hall of Fame inductee Eminem is coming back to Marvel Comics for an Amazing Spider-Man #1 variant cover which pits Eminem against Spider-Man himself in an image that pays homage to the climactic rap battle scene of Eminem’s 2002 biopic film 8 Mile, with Marvel characters like Miles Morales, Ghost-Spider, Daredevil, and Luke Cage in the audience. 

“HONORED to be on the official variant of The Amazing Spider-Man (2022),” tweeted the official Eminem Twitter account (opens in new tab) on November 21, along with an announcement that the variant will go on sale Tuesday, November 22 through Eminem’s website.

The new variant is for Amazing Spider-Man #1 (Legacy #895) which was released in April and is illustrated by Salvador Larroca and Edgar Delgado.

Amazing Spider-Man Eminem variant cover (Image credit: Marvel Comics)

(opens in new tab)

Eminem is the second hip hop legend to appear on a Marvel Comics cover this month. Christopher “Notorious B.I.G.” Wallace appeared on a variant cover to Deadpool #1, created in association with hustl., who is also working with Marvel for the Eminem cover. 

5,000 print copies are available for purchase on TheHaul.com (opens in new tab) and an additional 1,000 limited print run of the spotlight version of the variant comic cover will go on sale Tuesday, November 29.

“I’ve always been a huge Spider-Man fan since I was a kid,” Eminem says in Marvel’s official announcement. “He’s definitely in my top 5… So being on a cover battling Spider-Man is such a thrill and an honor.”

Eminem, oddly enough, is no stranger to Marvel Comics.

Way back in 2009, he co-starred alongside Frank Castle in Eminem/Punisher #1, in which Punisher teams up with Eminem to take on terrorists who interrupt one of his concerts. That comic was also drawn by Salvador Larroca. Additionally, Eminem provided theme songs for Sony’s 2018 Venom film and its 2021 sequel Let There Be Carnage.

Stay up to date on all the new Spider-Man comics Marvel has planned for release in 2022 and 2023.



Read original article here

Flu variant that hits kids and seniors harder than other strains is dominant in U.S. right now

A sign advertising flu shots is displayed at a Walgreens pharmacy on January 22, 2018 in San Francisco, California. A strong strain of H3N2 influenza has claimed the lives of 74 Californians under the age of 65 since the flu season began in October of last year.

Justin Sullivan | Getty Images

A variant of the flu that hits kids and seniors worse than other strains of the virus is dominant in the U.S. right now, setting the country up for a potentially bad flu season.

Public health labs have detected influenza A(H3N2) in 76% of the more than 3,500 respiratory samples that have tested positive for the flu and were analyzed for the virus subtype, according to a surveillance report published Friday by the Centers for Disease Control and Prevention.

The H3N2 variant has been associated with more severe flu seasons for children and the elderly in the past, according to Dr. Jose Romero, director the CDC’s National Center for Immunization and Respiratory Disease.

“There are also early signs of influenza causing severe illness in precisely these two groups of individuals this season,” Romero told reporters on a call earlier this month.

The flu hospitalization rate has surged to a decade high this season. Overall, about 8 people per 100,000 are being hospitalized with the flu right now but seniors and the youngest children are much harder hit than other age groups, according to CDC data.

The hospitalization rate for seniors is more than double the general population at 18 per 100,000. For kids younger than age five, the hospitalization rate is about 13 per 100,000.

CNBC Health & Science

Read CNBC’s latest global health coverage:

At least 4.4 million people have fallen ill with the flu, 38,000 have been hospitalized, and 2,100 have died since the season started. Seven kids have died from the flu so far this season.

“When we have more H3N2, we usually have a more severe flu season — so longer duration, more children affected, more children with severe disease,” said Dr. Andi Shane, a pediatrician and infectious disease expert at Children’s Healthcare Atlanta.

The other influenza A variant, H1N1, is generally associated with less severe seasons compared with H3N2, Shane said. H1N1 makes up about 22% of sample that have tested positive for flu and were analyzed for a subtype, according to CDC.

The percentage of patients reporting symptoms similar to the flu, a fever of 100 degrees or greater plus a sore throat or cough, is the highest in Virginia, Tennessee, South Carolina, Alabama and Washington D.C right now, according to CDC.

Respiratory illnesses are also very high in Arkansas, Colorado, Georgia, Kentucky, New Jersey, Maryland, Mississippi, New Mexico, North Carolina and Texas, according to CDC.

The CDC recommends that everyone 6 months or older get a flu shot. Children younger than age 8 who are receiving the vaccine for the first time should get two doses for the best protection.

The flu vaccine is normally 40% to 60% effective at preventing illness, but people who do still get sick are less likely to end up in the hospital or die, according to the CDC.

Public health officials are also encouraging people to stay home when they are sick, cover coughs and sneezes and wash hands frequently. Those who want to take extra precautions can consider wearing a facemask indoors in public.

Read original article here

BQ.1 COVID-19 variant becomes increasingly prevalent in US infections: CDC

A new subvariant of the omicron variant of the coronavirus is becoming increasingly prevalent in the United States, according to data from the Centers for Disease Control and Prevention (CDC). 

CDC data shows that the BQ.1 and BQ.1.1 variants each made up 5.7 percent of the total number of cases in the country in the past week. The BA.5 subvariant, which has dominated the cases in the U.S. for months, made up 67.9 percent, down from its peak in late August when it made up almost 90 percent of all cases in the country. 

The BQ.1 and BQ.1.1 variants have increasingly spread in recent weeks, only trailing the BA.5 and BA.4.6 subvariants in making up the most cases. 

Anthony Fauci, the director of the National Institute of Allergy and Infectious Diseases and President Biden’s chief medical adviser, told CBS News in an interview that people need to “keep our eye out” for emerging variants despite cases and hospitalizations being down. 

“When you get variants like that, you look at what their rate of increase is as a relative proportion of the variants, and this has a pretty troublesome doubling time,” he said. 

Fauci said he is worried that subsequent variants may be more effective at evading medications that scientists have developed to help patients manage the virus. 

“That’s the reason why people are concerned about BQ.1.1, for the double reason of its doubling time and the fact that it seems to elude important monoclonal antibodies,” he said. 

Cases and hospitalizations have dropped since July, and deaths have been decreasing since August. But health officials have warned the public to expect an increase in cases as the winter approaches. 

The Food and Drug Administration has authorized an updated booster dose of Pfizer and Moderna’s COVID-19 vaccines to address the omicron subvariants. The booster is a bivalent vaccine, meaning it contains the mRNA vaccine for the original strain of the coronavirus and the vaccine for another strain. 

This booster is targeting the BA.4 and BA.5 subvariants.

Read original article here

Coronavirus cases: Research sheds light on an emerging parallel COVID epidemic amid new variant, lingering symptoms

LOS ANGELES — Because so many people have dealt with COVID-19 infections, many now view the virus like a common cold or flu.

New research suggests that’s far from the truth. With concern over COVID waning, a parallel pandemic is emerging.

READ MORE | Long COVID symptoms plague sufferers, but new studies could lead to treatments and relief

“We’re still learning about the long term health effects of COVID infections,” said Los Angeles County Public Health Director Barbara Ferrer.

Dr. Michael Ghobrial with the Cleveland Clinic said they’re seeing it more commonly in younger patients.

READ MORE | Long haul COVID in kids symptoms, lingering effects still poorly understood

This comes as doctors across the country are dealing with a growing number of patients who can’t shake their initial COVID symptoms or have acquired new symptoms that last for at least a month or more. Some cases have been going on for two years.

“The most described symptoms of long COVID include fatigue, reduced exercise capacity, breathing problems, brain fog and loss of taste or smell,” said Ferrer.

Various studies find long COVID, or long haulers syndrome, can strike in all populations.

READ MORE | Future uncertain for COVID ‘long-haulers’ struggling with chronic illness

“It’s more in females compared to males. It’s also more common in patients who have comorbidities,” said Ghobrial.

In a study of several thousand veterans, Ferrer said the new evidence suggests repeated COVID infections increase one’s risk for long haul syndrome.

“Many of these disorders were serious and life changing and included stroke, cognition and memory disorders, peripheral nervous system disorders,” she said. “The risk of having long term health conditions was three times higher for those infected three times compared to those who were uninfected.”

Avoiding infection is the key, and while COVID vaccines and boosters don’t always prevent infection, numerous studies find it can reduce the risk of long COVID.

“Those who had two doses of vaccine before getting COVID had an approximately 75% lower chance of getting long COVID,” said Ferrer. “While those who got three doses had an 84% lower chance of getting long COVID.”

While we have much to learn, Ferrer said getting vaccinated and boosted appears to be one of the simplest ways to significantly reduce your risk.

Copyright © 2022 KABC Television, LLC. All rights reserved.



Read original article here

Coronavirus cases: Research sheds light on an emerging parallel COVID epidemic amid new variant, lingering symptoms

LOS ANGELES — Because so many people have dealt with COVID-19 infections, many now view the virus like a common cold or flu.

New research suggests that’s far from the truth.

With concern over COVID waning, a parallel pandemic is emerging.

“We’re still learning about the long term health effects of COVID infections,” said Los Angeles County Public Health Director Barbara Ferrer.

SEE ALSO | 80% with long COVID have debilitating conditions: CDC

Dr. Michael Ghobrial with the Cleveland Clinic said they’re seeing it more commonly in younger patients.

This comes as doctors across the country are dealing with a growing number of patients who can’t shake their initial COVID symptoms or have acquired new symptoms that last for at least a month or more. Some cases have been going on for two years.

“The most described symptoms of long COVID include fatigue, reduced exercise capacity, breathing problems, brain fog and loss of taste or smell,” said Ferrer.

Various studies find long COVID, or long haulers syndrome, can strike in all populations.

“It’s more in females compared to males. It’s also more common in patients who have comorbidities,” said Ghobrial.

In a study of several thousand veterans, Ferrer said the new evidence suggests repeated COVID infections increase one’s risk for long haul syndrome.

RELATED | COVID US: CDC drops traveler health notices for individual countries

“Many of these disorders were serious and life changing and included stroke, cognition and memory disorders, peripheral nervous system disorders,” she said. “The risk of having long term health conditions was three times higher for those infected three times compared to those who were uninfected.”

Avoiding infection is the key, and while COVID vaccines and boosters don’t always prevent infection, numerous studies find it can reduce the risk of long COVID.

“Those who had two doses of vaccine before getting COVID had an approximately 75% lower chance of getting long COVID,” said Ferrer. “While those who got three doses had an 84% lower chance of getting long COVID.”

While we have much to learn, Ferrer said getting vaccinated and boosted appears to be one of the simplest ways to significantly reduce your risk.

Copyright © 2022 KABC Television, LLC. All rights reserved.



Read original article here